ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 137 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 8.14 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $7,714,000 | -58.9% | 752,575 | -33.3% | 0.03% | -50.9% |
| Q3 2018 | $18,786,000 | +10.2% | 1,128,303 | +4.6% | 0.05% | +1.9% |
| Q2 2018 | $17,042,000 | +25.9% | 1,078,596 | +1.2% | 0.05% | +18.2% |
| Q1 2018 | $13,540,000 | +37.1% | 1,066,164 | +23.6% | 0.04% | +41.9% |
| Q4 2017 | $9,877,000 | +40.6% | 862,585 | +50.4% | 0.03% | +34.8% |
| Q3 2017 | $7,025,000 | +14.1% | 573,465 | +6.6% | 0.02% | +21.1% |
| Q2 2017 | $6,158,000 | -43.6% | 537,835 | +2.4% | 0.02% | -48.6% |
| Q1 2017 | $10,923,000 | +5.5% | 525,128 | +5.5% | 0.04% | 0.0% |
| Q4 2016 | $10,358,000 | -31.3% | 497,953 | +8.3% | 0.04% | -28.8% |
| Q3 2016 | $15,072,000 | +41.5% | 459,912 | +7.8% | 0.05% | +40.5% |
| Q2 2016 | $10,650,000 | +14.2% | 426,490 | +12.0% | 0.04% | +15.6% |
| Q1 2016 | $9,322,000 | -25.7% | 380,674 | +0.3% | 0.03% | -25.6% |
| Q4 2015 | $12,538,000 | +120.6% | 379,579 | +118.8% | 0.04% | +115.0% |
| Q3 2015 | $5,683,000 | +48.3% | 173,471 | +139.8% | 0.02% | +66.7% |
| Q2 2015 | $3,832,000 | – | 72,336 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,203 | $36,042,000 | 9.93% |
| Foresite Capital Management II, LLC | 1,043,832 | $12,787,000 | 5.18% |
| Redmile Group, LLC | 6,476,766 | $79,340,000 | 3.91% |
| DAFNA Capital Management LLC | 346,013 | $4,239,000 | 2.63% |
| Cormorant Asset Management, LP | 900,000 | $11,025,000 | 1.95% |
| SENZAR ASSET MANAGEMENT, LLC | 641,170 | $7,854,000 | 1.92% |
| Asymmetry Capital Management, L.P. | 105,228 | $1,289,000 | 1.50% |
| New Leaf Venture Partners, L.L.C. | 171,364 | $2,099,000 | 0.97% |
| EMERALD ADVISERS, LLC | 1,578,477 | $19,336,000 | 0.79% |
| BB BIOTECH AG | 2,266,008 | $27,759,000 | 0.77% |